Detalles de la búsqueda
1.
Population Pharmacokinetics and Dose Evaluation of Cycloserine among Patients with Multidrug-Resistant Tuberculosis under Standardized Treatment Regimens.
Antimicrob Agents Chemother
; 67(5): e0170022, 2023 05 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37097151
2.
Post COVID-19 condition diagnosis: A population-based cohort study of occurrence, associated factors, and healthcare use by severity of acute infection.
J Intern Med
; 293(2): 246-258, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36478477
3.
Cardiorespiratory dysautonomia in post-COVID-19 condition: Manifestations, mechanisms and management.
J Intern Med
; 294(5): 548-562, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37183186
4.
Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial.
BMC Infect Dis
; 23(1): 33, 2023 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36670365
5.
Drug exposure and susceptibility of second-line drugs correlate with treatment response in patients with multidrug-resistant tuberculosis: a multicentre prospective cohort study in China.
Eur Respir J
; 59(3)2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34737224
6.
Drug Exposure and Minimum Inhibitory Concentration Predict Pulmonary Tuberculosis Treatment Response.
Clin Infect Dis
; 73(9): e3520-e3528, 2021 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33070176
7.
Genotypic Resistance of Pyrazinamide but Not Minimum Inhibitory Concentration Is Associated With Longer Time to Sputum Culture Conversion in Patients With Multidrug-resistant Tuberculosis.
Clin Infect Dis
; 73(9): e3511-e3517, 2021 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33011791
8.
Evaluation of the latent tuberculosis screening and treatment strategy for asylum seekers in Stockholm, Sweden 2015-2018: a record linkage study of the care cascade.
Eur Respir J
; 57(3)2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32855227
9.
Drug exposure of first-line anti-tuberculosis drugs in China: A prospective pharmacological cohort study.
Br J Clin Pharmacol
; 87(3): 1347-1358, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33464624
10.
Increased risk of active tuberculosis during pregnancy and postpartum: a register-based cohort study in Sweden.
Eur Respir J
; 55(3)2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31862768
11.
Screening and treatment of tuberculosis among pregnant women in Stockholm, Sweden, 2016-2017.
Eur Respir J
; 55(3)2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31949114
12.
Minimum Inhibitory Concentrations of Fluoroquinolones and Pyrazinamide Susceptibility Correlate to Clinical Improvement in Multidrug-resistant Tuberculosis Patients: A Nationwide Swedish Cohort Study Over 2 Decades.
Clin Infect Dis
; 69(8): 1394-1402, 2019 09 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30561569
13.
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.
Eur Respir J
; 54(6)2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31601711
14.
Individualised dosing algorithm and personalised treatment of high-dose rifampicin for tuberculosis.
Br J Clin Pharmacol
; 85(10): 2341-2350, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31269277
15.
Quality of life of patients on treatment for latent tuberculosis infection: a mixed-method study in Stockholm, Sweden.
Health Qual Life Outcomes
; 17(1): 158, 2019 Oct 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31651339
16.
Diagnostic pathways and delay among tuberculosis patients in Stockholm, Sweden: a retrospective observational study.
BMC Public Health
; 19(1): 151, 2019 Feb 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30717738
17.
Plasma Levels of Rifampin Correlate with the Tuberculosis Drug Activity Assay.
Antimicrob Agents Chemother
; 62(5)2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29483112
18.
Distribution of plasma concentrations of first-line anti-TB drugs and individual MICs: a prospective cohort study in a low endemic setting.
J Antimicrob Chemother
; 73(10): 2838-2845, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30124844
19.
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.
Eur Respir J
; 49(5)2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28529205
20.
Suboptimal moxifloxacin and levofloxacin drug exposure during treatment of patients with multidrug-resistant tuberculosis: results from a prospective study in China.
Eur Respir J
; 57(3)2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33154028